ARID1B RESEARCH FOUNDATION INC

EIN: 881940774 501(c)(3) Diseases & Disorders

CHEVY CHASE, MD

Total Revenue
$311,126
Total Expenses
$159,086
Total Assets
$177,821
Net Assets
$177,821
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2022
Legal Domicile
DE
Phone
9253866664
Tax Period
2023-01-01 to 2023-12-31

ARID1B RESEARCH FOUNDATION INC, founded in 2022, is a small nonprofit in the Diseases & Disorders sector that reported $311K in total revenue in fiscal year 2023. Revenue surged 1009% from the prior year, signaling strong growth momentum. The organization ran a surplus of $152K, a strong 49% operating margin.

Mission

To advance the scientific and clinical understanding of disorders associated with ARID1B gene and the development of potential therapies for such disorders.

Program Service Accomplishments

Program 1
Expenses: $150,761

Funding research and the development of treatment for those impacted by ARID1B related disorders.The first grant to a research organization was made in March 2023.In May 2024, FAR announced that the...

Read more

Funding research and the development of treatment for those impacted by ARID1B related disorders.The first grant to a research organization was made in March 2023.In May 2024, FAR announced that the first-ever ARID1B-RD gene therapy is advancing to pre-clinical testing. This marks a significant milestone in our quest for treatments for ARID1B-RD. One of the labs we are working with has successfully secured the necessary funding to test the potential genetic treatment they developed on ARID1B-RD mice and brain organoids. Currently, the team is establishing a colony of transgenic mice that carry a mutation in the ARID1B gene. In a few months, they will administer the treatment to these mice and assess their social and cognitive functions, hoping to demonstrate improvements to match those of their typical peers. Simultaneously, two additional researchers are collaborating with another team to explore the effects of the treatment on the most advanced ARID1B-RD brain organoids developed to date.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $311,126
Program Service Revenue $0
Investment Income $0
Other Revenue $0
TOTAL REVENUE $311,126

Expense Breakdown

Grants Paid $150,761
Salaries & Benefits $0
Fundraising Expenses $3,548
Program Expenses $150,761
Other Expenses $8,325
TOTAL EXPENSES $159,086

Year-over-Year Comparison

2023 2022 Change
Revenue $311,126 $28,047 +10.1%
Expenses $159,086 $2,266 +69.2%
Net Income $152,040 $25,781 +4.9%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
6
Independent Members
N/A
Employees
N/A
Volunteers
N/A

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
3
$0
Total Directors
6
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Gal Lazarus BOARD CHAIR 8.00
Officer Director
$0 $0 $0
Elizabeth Dodson Treasurer 2.00
Officer Director
$0 $0 $0
Rachael Vitalo Secretary 2.00
Officer Director
$0 $0 $0
Clarissa Ward BOARD MEMBER 3.00
Director
$0 $0 $0
Caroline Olshewsky BOARD MEMBER 6.00
Director
$0 $0 $0
Omri Besor BOARD MEMBER 2.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $311,126 $159,086 $177,821 $152,040
Explore More Nonprofits
Top 100 Nonprofits in Maryland Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare ARID1B RESEARCH FOUNDATION INC with other nonprofits in Maryland and across the country.